These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30660695)

  • 1. Screening a trace amount of pharmaceutical cocrystals by using an enhanced nano-spot method.
    Tanabe Y; Maeno Y; Ohashi K; Hisada H; Roy A; Carriere J; Heyler R; Fukami T
    Eur J Pharm Biopharm; 2019 Mar; 136():131-137. PubMed ID: 30660695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
    Li Z; Matzger AJ
    Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms by which moisture generates cocrystals.
    Jayasankar A; Good DJ; Rodríguez-Hornedo N
    Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
    Boksa K; Otte A; Pinal R
    J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction crystallization of pharmaceutical molecular complexes.
    Rodríguez-Hornedo N; Nehm SJ; Seefeldt KF; Pagan-Torres Y; Falkiewicz CJ
    Mol Pharm; 2006; 3(3):362-7. PubMed ID: 16749868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of cocrystal cocktail grinding method for rational screening of pharmaceutical cocrystals.
    Yamamoto K; Tsutsumi S; Ikeda Y
    Int J Pharm; 2012 Nov; 437(1-2):162-71. PubMed ID: 22871562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of varying quantities of polymer on preparation and stability evaluation of carbamazepine cocrystals with dicarboxylic acid coformers.
    Wasim M; Mannan A; Ullah K; Yameen MA; Latif M; Ahmad T; Ullah M; Amirzada MI; Khan HU; Maheen S; Khan SA; Jamil QA; Bin Asad MHH; Hussain I
    Pak J Pharm Sci; 2020 Jul; 33(4(Supplementary)):1755-1761. PubMed ID: 33612458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
    Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
    Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of binding with the α-glucosidase in vitro and the evaluation on hypoglycemic effect in vivo: Cocrystals involving synergism of gallic acid and conformer.
    Xue N; He B; Jia Y; Yang C; Wang J; Li M
    Eur J Pharm Biopharm; 2020 Nov; 156():64-74. PubMed ID: 32890659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
    Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism and stability of ibuprofen/nicotinamide cocrystal: The effect of the crystalline synthesis method.
    Guerain M; Guinet Y; Correia NT; Paccou L; Danède F; Hédoux A
    Int J Pharm; 2020 Jun; 584():119454. PubMed ID: 32464230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of electrospray deposition for rapid screening of the cocrystal formation and single step, continuous production of pharmaceutical nanococrystals.
    Emami S; Siahi-Shadbad M; Barzegar-Jalali M; Adibkia K
    Drug Dev Ind Pharm; 2018 Jun; 44(6):1034-1047. PubMed ID: 29347850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental cocrystal screening and solution based scale-up cocrystallization methods.
    Malamatari M; Ross SA; Douroumis D; Velaga SP
    Adv Drug Deliv Rev; 2017 Aug; 117():162-177. PubMed ID: 28811184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Screening of Coformers for Active Pharmaceutical Ingredient Cocrystallization.
    Sugden IJ; Braun DE; Bowskill DH; Adjiman CS; Pantelides CC
    Cryst Growth Des; 2022 Jul; 22(7):4513-4527. PubMed ID: 35915670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Situ Cocrystallization of Dapsone and Caffeine during Fluidized Bed Granulation Processing.
    Todaro V; Worku ZA; Cabral LM; Healy AM
    AAPS PharmSciTech; 2019 Jan; 20(1):28. PubMed ID: 30603811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Monitoring of Cocrystal Polymorphisms in Model Tablets Using Transmission Low-Frequency Raman Spectroscopy.
    Inoue M; Osada T; Hisada H; Koide T; Fukami T; Roy A; Carriere J
    J Pharm Sci; 2023 Jan; 112(1):225-229. PubMed ID: 36126759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vibrational Spectroscopy for Cocrystals Screening. A Comparative Study.
    Rodrigues M; Lopes J; Sarraguça M
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-line monitoring of cocrystallization process and quantification of carbamazepine-nicotinamide cocrystal using Raman spectroscopy and chemometric tools.
    Soares FL; Carneiro RL
    Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jun; 180():1-8. PubMed ID: 28259099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations.
    Avdeef A
    Eur J Pharm Sci; 2017 Dec; 110():2-18. PubMed ID: 28392495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.